These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 29358841

  • 1. Usefulness of Age-Stratified N-Terminal Prohormone of Brain Natriuretic Peptide for Diagnosing Kawasaki Disease.
    Lee SH, Song ES, Yoon S, Hong S, Cho HJ, Yang EM, Eom GH, Kang G, Cho YK.
    Dis Markers; 2017; 2017():6263121. PubMed ID: 29358841
    [Abstract] [Full Text] [Related]

  • 2. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
    Ye Q, Shao WX, Shang SQ, Zhang T, Hu J, Zhang CC.
    Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686
    [Abstract] [Full Text] [Related]

  • 3. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.
    Reddy M, Singh S, Rawat A, Sharma A, Suri D, Rohit MK.
    Rheumatol Int; 2016 Apr; 36(4):551-9. PubMed ID: 26849890
    [Abstract] [Full Text] [Related]

  • 4. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
    Huiling L, Yaping L, Xiufen H.
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
    [Abstract] [Full Text] [Related]

  • 5. The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
    Shao S, Luo C, Zhou K, Hua Y, Wu M, Liu L, Liu X, Wang C.
    Pediatr Rheumatol Online J; 2019 Sep 18; 17(1):65. PubMed ID: 31533770
    [Abstract] [Full Text] [Related]

  • 6. N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease.
    Kwon H, Lee JH, Jung JY, Kwak YH, Kim DK, Jung JH, Chang I, Kim K.
    Eur J Pediatr; 2016 Dec 18; 175(12):1997-2003. PubMed ID: 27798729
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of age-adjusted N-terminal prohormone of brain natriuretic peptide level as a diagnostic marker for incomplete Kawasaki disease in children.
    Rodríguez-González M, Castellano-Martínez A, Alonso-Ojembarrena A.
    Emergencias; 2016 Dec 18; 31(2):111-114. PubMed ID: 30963739
    [Abstract] [Full Text] [Related]

  • 8. Value of amino-terminal pro B-natriuretic peptide in diagnosing Kawasaki disease.
    McNeal-Davidson A, Fournier A, Spigelblatt L, Saint-Cyr C, Mir TS, Nir A, Dallaire F, Cousineau J, Delvin E, Dahdah N.
    Pediatr Int; 2012 Oct 18; 54(5):627-33. PubMed ID: 22414326
    [Abstract] [Full Text] [Related]

  • 9. Risk of coronary artery lesions in young infants with Kawasaki disease: need for a new diagnostic method.
    Satoh K, Wakejima Y, Gau M, Kiguchi T, Matsuda N, Takasawa R, Takasawa K, Nishioka M, Shimohira M.
    Int J Rheum Dis; 2018 Mar 18; 21(3):746-754. PubMed ID: 29105337
    [Abstract] [Full Text] [Related]

  • 10. Expression levels of plasma miRNA-21 and NT-proBNP in children with Kawasaki disease and their clinical significance.
    Zhang R, Wu L, Zhang HJ, Gao XJ, Pan XT, Wang XR, Ye H, Liu GH.
    Eur Rev Med Pharmacol Sci; 2020 Dec 18; 24(24):12757-12762. PubMed ID: 33378024
    [Abstract] [Full Text] [Related]

  • 11. Cardiac function on 3-D speckle tracking imaging and cytokines in Kawasaki disease.
    Kato M, Ayusawa M, Watanabe H, Komori A, Abe Y, Nakamura T, Kamiyama H, Takahashi S.
    Pediatr Int; 2018 Apr 18; 60(4):342-348. PubMed ID: 29350882
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis.
    Lin KH, Chang SS, Yu CW, Lin SC, Liu SC, Chao HY, Lee MT, Wu JY, Lee CC.
    BMJ Open; 2015 Apr 14; 5(4):e006703. PubMed ID: 25872939
    [Abstract] [Full Text] [Related]

  • 13. N-terminal pro-B-type natriuretic peptide diagnostic algorithm versus American Heart Association algorithm for Kawasaki disease.
    Dionne A, Meloche-Dumas L, Desjardins L, Turgeon J, Saint-Cyr C, Autmizguine J, Spigelblatt L, Fournier A, Dahdah N.
    Pediatr Int; 2017 Mar 14; 59(3):265-270. PubMed ID: 27589358
    [Abstract] [Full Text] [Related]

  • 14. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
    Zhang QY, Du JB, Chen YH, Li WZ.
    Zhonghua Er Ke Za Zhi; 2006 Dec 14; 44(12):886-90. PubMed ID: 17254452
    [Abstract] [Full Text] [Related]

  • 15. A comparative study of IL-6, CRP and NT-proBNP levels in post-COVID multisystem inflammatory syndrome in children (MISC) and Kawasaki disease patients.
    Ganguly M, Nandi A, Banerjee P, Gupta P, Sarkar SD, Basu S, Pal P.
    Int J Rheum Dis; 2022 Jan 14; 25(1):27-31. PubMed ID: 34750969
    [Abstract] [Full Text] [Related]

  • 16. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
    Yoshimura K, Kimata T, Mine K, Uchiyama T, Tsuji S, Kaneko K.
    J Pediatr; 2013 Jun 14; 162(6):1205-9. PubMed ID: 23290510
    [Abstract] [Full Text] [Related]

  • 17. Blood N-terminal Pro-brain Natriuretic Peptide and Interleukin-17 for Distinguishing Incomplete Kawasaki Disease from Infectious Diseases.
    Wu L, Chen Y, Zhong S, Li Y, Dai X, Di Y.
    Indian Pediatr; 2015 Jun 14; 52(6):477-80. PubMed ID: 26121721
    [Abstract] [Full Text] [Related]

  • 18. Factors affecting N-terminal pro-brain natriuretic peptide elevation in the acute phase of Kawasaki disease.
    Yanagisawa D, Ayusawa M, Kato M, Watanabe H, Komori A, Abe Y, Nakamura T, Kamiyama H, Takahashi S.
    Pediatr Int; 2016 Nov 14; 58(11):1105-1111. PubMed ID: 26991905
    [Abstract] [Full Text] [Related]

  • 19. Echocardiographic Parameters During and Beyond Onset of Kawasaki Disease Correlate with Onset Serum N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP).
    Desjardins L, Dionne A, Meloche-Dumas L, Fournier A, Dahdah N.
    Pediatr Cardiol; 2020 Jun 14; 41(5):947-954. PubMed ID: 32172336
    [Abstract] [Full Text] [Related]

  • 20. N-terminal pro-brain natriuretic peptide and prediction of coronary artery dilatation in hyperacute phase of Kawasaki disease.
    Jung JY, Ham EM, Kwon H, Kwak YH, Kim DK, Lee JH, Jung JH.
    Am J Emerg Med; 2019 Mar 14; 37(3):468-471. PubMed ID: 29903669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.